| Kimberly Glendoria Wallen, CRNA | |
|
3334 Monida St, Bozeman, MT 59718-8648 | |
| (804) 647-1635 | |
| Not Available |
| Full Name | Kimberly Glendoria Wallen |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 3334 Monida St, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033575907 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 146248 (Montana) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 108532 (Kansas) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Anesthesia Care | 6103288147 | 3 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | Livingston Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245222306 PECOS PAC ID: 5991613598 Enrollment ID: O20031122000111 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | Powell County Memorial Hospital Association Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841414026 PECOS PAC ID: 6103734728 Enrollment ID: O20040917001067 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | Diamond Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912553280 PECOS PAC ID: 5698005296 Enrollment ID: O20190925000427 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | U S Anesthesia Partners Of Montana P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588359855 PECOS PAC ID: 8022474675 Enrollment ID: O20230524000324 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | Advanced Anesthesia Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124710207 PECOS PAC ID: 6103288147 Enrollment ID: O20230808003150 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Entity Name | Anesthesia Consulting Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053092189 PECOS PAC ID: 4688037039 Enrollment ID: O20230831004207 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Glendoria Wallen, CRNA 3334 Monida St, Bozeman, MT 59718-8648 Ph: (804) 647-1635 | Kimberly Glendoria Wallen, CRNA 3334 Monida St, Bozeman, MT 59718-8648 Ph: (804) 647-1635 |
News Archive
A research team jointly led by scientists from Cedars-Sinai Medical Center and the University of California, Los Angeles, have enhanced a device they developed to identify and "grab" circulating tumor cells, or CTCs, that break away from cancers and enter the blood, often leading to the spread of cancer to other parts of the body.
GE Healthcare signed an agreement with Affibody AB to collaborate on the development of a Her2-targeted PET imaging agent, which is scheduled to begin clinical trials later this year.
Researchers from Mount Sinai School of Medicine are pioneering new ultrasound techniques that provide the first characterization of multidirectional blood flow in the heart. By focusing on fluid dynamics - specifically, the efficiency with which blood enters and exits the heart's left ventricle - the researchers believe they can detect heart disease even when traditional measures show no sign of trouble.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 6 days ago
Tara Munroe, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 925 Highland Blvd Ste 1180, Bozeman, MT 59715 Phone: 406-582-4963 Fax: 706-396-3252 | |
Ms. Geraldine Brenda Lyman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 300 N Willson Ave, Same Day Surgery Center, Bozeman, MT 59715 Phone: 406-585-9662 Fax: 406-587-7656 | |
Mrs. Lauri Louise Ferraro, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 300 N Willson Ave, Same Day Surgery Center, Bozeman, MT 59715 Phone: 406-586-1956 Fax: 406-587-7656 |